Kanagawa, Japan

Yoshitaka Nakamura

This inventor holds 31 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Bicyclic Compound Synthesis. Top assignees: Fujitsu Corporation, Daiichi Sankyo Company, Limited, Fujitsu Media Devices Limited. Active years: 2001-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshitaka Nakamura. Retrieved from https://idiyas.com/inventor/yoshitaka-nakamura-3ueydy3d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

% Patents Active = 58.1


 

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 102(Granted Patents)


Location History:

  • Kawasaki, JP (2001)
  • Suzaka, JP (2004 - 2006)
  • Hiratsuka, JP (2014)
  • Yokohama, JP (2003 - 2016)
  • Kanagawa, JP (2009 - 2016)

Company Filing History:


Years Active: 2001-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bicyclic Compounds
Optical Resolution
Immune Modulation
Neuraminic Acid
Micro-Oscillation Elements
Inertial Sensors
Pyrrole Derivatives
Rotavirus Compositions
Surface-Acoustic-Wave Filters
Claisen Rearrangements
Iminium Salts
Enzyme Methods
31 patents (USPTO):Explore Patents

Title: The Innovations of Yoshitaka Nakamura

Introduction

Yoshitaka Nakamura, based in Kanagawa, Japan, is a prominent inventor with an impressive portfolio of 31 patents. His contributions have significantly advanced the fields of organic chemistry and pharmaceutical development.

Latest Patents

Among his latest patents, Nakamura has developed a preparation method for optically active bicyclic gamma-amino acid compound, aimed at achieving high purity in optically active bicyclic γ-amino acid derivatives. This innovation utilizes a mixture of specific compounds to produce desirable outcomes in purity and efficacy.

Another notable invention is the preparation method of optically active diamine compounds, which addresses the production of important intermediate compounds used in the development of FXa inhibitors. His approach incorporates a stereoselective intramolecular cyclization reaction, enhancing the efficiency of creating these essential compounds.

Career Highlights

Nakamura has had a distinguished career, contributing to leading organizations such as Fujitsu Corporation and Daiichi Sankyo Company, Limited. His work in these respected companies has allowed him to push the boundaries of innovation in chemical compounds and their applications in medicine.

Collaborations

Throughout his career, Nakamura has collaborated with esteemed colleagues, including Osamu Tsuboi and Norinao Kouma. These partnerships have fostered a creative environment, enabling the successful development of various projects and inventions.

Conclusion

Yoshitaka Nakamura's achievements in the field of patentable innovations underscore his dedication to advancing science and technology. His inventions, particularly in the realm of optically active compounds, demonstrate his impactful contributions to pharmaceuticals and organic chemistry. As he continues to innovate, the future holds great promise for his work and its applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…